"Blood Substitutes" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Substances that are used in place of blood, for example, as an alternative to BLOOD TRANSFUSIONS after blood loss to restore BLOOD VOLUME and oxygen-carrying capacity to the blood circulation, or to perfuse isolated organs.
| Descriptor ID |
D001802
|
| MeSH Number(s) |
D27.505.954.502.140 J01.637.087.249
|
| Concept/Terms |
Blood Substitutes- Blood Substitutes
- Blood Substitute
- Substitute, Blood
- Substitutes, Blood
- Artificial Blood
- Artificial Bloods
- Bloods, Artificial
- Blood, Artificial
Artificial Erythrocytes- Artificial Erythrocytes
- Artificial Erythrocyte
- Erythrocyte, Artificial
- Erythrocytes, Artificial
- Red Cell Substitutes
- Cell Substitute, Red
- Cell Substitutes, Red
- Red Cell Substitute
- Substitute, Red Cell
- Substitutes, Red Cell
- Erythrocyte Substitutes
- Erythrocyte Substitute
- Substitute, Erythrocyte
- Substitutes, Erythrocyte
Artificial Hemoglobin- Artificial Hemoglobin
- Artificial Hemoglobins
- Hemoglobin, Artificial
- Hemoglobins, Artificial
- Hemoglobin Substitutes
- Hemoglobin Substitute
- Substitute, Hemoglobin
- Substitutes, Hemoglobin
|
Below are MeSH descriptors whose meaning is more general than "Blood Substitutes".
Below are MeSH descriptors whose meaning is more specific than "Blood Substitutes".
This graph shows the total number of publications written about "Blood Substitutes" by people in this website by year, and whether "Blood Substitutes" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 1 | 0 | 1 |
| 2002 | 2 | 0 | 2 |
| 2003 | 1 | 0 | 1 |
| 2004 | 1 | 0 | 1 |
| 2006 | 0 | 1 | 1 |
| 2008 | 2 | 0 | 2 |
| 2014 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Blood Substitutes" by people in Profiles.
-
Pathak R, Bhatt VR, Karmacharya P, Aryal MR, Alweis R. Trends in blood-product transfusion among inpatients in the United States from 2002 to 2011: data from the Nationwide Inpatient Sample. J Hosp Med. 2014 Dec; 9(12):800-1.
-
Moore EE, Moore FA, Fabian TC, Bernard AC, Fulda GJ, Hoyt DB, Duane TM, Weireter LJ, Gomez GA, Cipolle MD, Rodman GH, Malangoni MA, Hides GA, Omert LA, Gould SA. Human polymerized hemoglobin for the treatment of hemorrhagic shock when blood is unavailable: the USA multicenter trial. J Am Coll Surg. 2009 Jan; 208(1):1-13.
-
Minneci PC, Deans KJ, Shiva S, Zhi H, Banks SM, Kern S, Natanson C, Solomon SB, Gladwin MT. Nitrite reductase activity of hemoglobin as a systemic nitric oxide generator mechanism to detoxify plasma hemoglobin produced during hemolysis. Am J Physiol Heart Circ Physiol. 2008 Aug; 295(2):H743-54.
-
Rogers DM, Crookston KP. The approach to the patient who refuses blood transfusion. Transfusion. 2006 Sep; 46(9):1471-7.
-
Anbari KK, Garino JP, Mackenzie CF. Hemoglobin substitutes. Eur Spine J. 2004 Oct; 13 Suppl 1:S76-82.
-
Khan AK, Jahr JS, Nesargi S, Rothenberg SJ, Tang Z, Cheung A, Gunther RA, Kost GJ, Driessen B. Does lead interfere with hemoglobin-based oxygen carrier (HBOC) function? A pilot study of lead concentrations in three approved or tested HBOCs and oxyhemoglobin dissociation with HBOCs and/or bovine blood with varying lead concentrations. Anesth Analg. 2003 Jun; 96(6):1813-1820.
-
Lanzkron S, Moliterno AR, Norris EJ, Gould SA, Segal J, Nuermberger EL, Ness PM. Polymerized human Hb use in acute chest syndrome: a case report. Transfusion. 2002 Nov; 42(11):1422-7.
-
Jahr JS, Nesargi SB, Lewis K, Johnson C. Blood substitutes and oxygen therapeutics: an overview and current status. Am J Ther. 2002 Sep-Oct; 9(5):437-43.
-
Sloan EP, Koenigsberg M, Gens D, Cipolle M, Runge J, Mallory MN, Rodman G. Diaspirin cross-linked hemoglobin (DCLHb) in the treatment of severe traumatic hemorrhagic shock: a randomized controlled efficacy trial. JAMA. 1999 Nov 17; 282(19):1857-64.
-
Breuninger HG, Wolfson MR, Rubenstein SD, Shaffer TH. Effect of exchange transfusion with a red blood cell substitute on the neonatal lung. J Dev Physiol. 1990 Nov; 14(5):283-9.